title: Complete androgen blockade: data from an EORTC 30853 trial.
authors: Department of Urology, A.Z. Middelheim, Antwerp, Belgium.
authors: L
authors: L
authors: Denis
authors: F
authors: F
authors: Keuppens
authors: M
authors: M
authors: Robinson
authors: C
authors: C
authors: Mahler
authors: P
authors: P
authors: Smith
authors: A P
authors: AP
authors: Pinto de Carvalho
authors: D
authors: D
authors: Newling
authors: A
authors: A
authors: Bono
authors: R
authors: R
authors: Sylvester
authors: M
authors: M
authors: De Pauw
mesh_terms: D000368:Aged; D000813:Anilides / Q000627:therapeutic use*; D002064:Buserelin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005060:Europe; D005485:Flutamide / Q000627:therapeutic use*; D017273:Goserelin; D006801:Humans; D008297:Male; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D009919:Orchiectomy; D011471:Prostatic Neoplasms / Q000401:mortality / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate
chemical_list: D000813:Anilides; D017273:Goserelin; D005485:Flutamide; D002064:Buserelin